Cargando…
Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards
The hazard ratio (HR) is the most common measure of treatment effect in clinical trials that use time-to-event outcomes such as survival. When survival curves cross over or separate only after a considerable time, the proportional hazards assumption of the Cox model is violated, and HR can be mislea...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444092/ https://www.ncbi.nlm.nih.gov/pubmed/28546261 http://dx.doi.org/10.1136/bmj.j2250 |
_version_ | 1783238671961423872 |
---|---|
author | Dehbi, Hakim-Moulay Royston, Patrick Hackshaw, Allan |
author_facet | Dehbi, Hakim-Moulay Royston, Patrick Hackshaw, Allan |
author_sort | Dehbi, Hakim-Moulay |
collection | PubMed |
description | The hazard ratio (HR) is the most common measure of treatment effect in clinical trials that use time-to-event outcomes such as survival. When survival curves cross over or separate only after a considerable time, the proportional hazards assumption of the Cox model is violated, and HR can be misleading. We present two measures of treatment effects for situations where the HR changes over time: the life expectancy difference (LED) and life expectancy ratio (LER). LED is the difference between mean survival times in the intervention and control arms. LER is the ratio of these two times. LED and LER can be calculated for at least two time intervals during the trial, allowing for curves where the treatment effect changes over time. The two measures are readily interpretable as absolute and relative gains or losses in life expectancy. |
format | Online Article Text |
id | pubmed-5444092 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BMJ Publishing Group Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-54440922017-05-26 Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards Dehbi, Hakim-Moulay Royston, Patrick Hackshaw, Allan BMJ Research Methods & Reporting The hazard ratio (HR) is the most common measure of treatment effect in clinical trials that use time-to-event outcomes such as survival. When survival curves cross over or separate only after a considerable time, the proportional hazards assumption of the Cox model is violated, and HR can be misleading. We present two measures of treatment effects for situations where the HR changes over time: the life expectancy difference (LED) and life expectancy ratio (LER). LED is the difference between mean survival times in the intervention and control arms. LER is the ratio of these two times. LED and LER can be calculated for at least two time intervals during the trial, allowing for curves where the treatment effect changes over time. The two measures are readily interpretable as absolute and relative gains or losses in life expectancy. BMJ Publishing Group Ltd. 2017-05-25 /pmc/articles/PMC5444092/ /pubmed/28546261 http://dx.doi.org/10.1136/bmj.j2250 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Methods & Reporting Dehbi, Hakim-Moulay Royston, Patrick Hackshaw, Allan Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards |
title | Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards |
title_full | Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards |
title_fullStr | Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards |
title_full_unstemmed | Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards |
title_short | Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards |
title_sort | life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards |
topic | Research Methods & Reporting |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444092/ https://www.ncbi.nlm.nih.gov/pubmed/28546261 http://dx.doi.org/10.1136/bmj.j2250 |
work_keys_str_mv | AT dehbihakimmoulay lifeexpectancydifferenceandlifeexpectancyratiotwomeasuresoftreatmenteffectsinrandomisedtrialswithnonproportionalhazards AT roystonpatrick lifeexpectancydifferenceandlifeexpectancyratiotwomeasuresoftreatmenteffectsinrandomisedtrialswithnonproportionalhazards AT hackshawallan lifeexpectancydifferenceandlifeexpectancyratiotwomeasuresoftreatmenteffectsinrandomisedtrialswithnonproportionalhazards |